Spranger S - Search Results

1

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression.

Nguyen KB, Roerden M, Copeland CJ, Backlund CM, Klop-Packel NG, Remba T, Kim B, Singh NK, Birnbaum ME, Irvine DJ, Spranger S. Nguyen KB, et al. Among authors: spranger s. Elife. 2023 Aug 7;12:e85263. doi: 10.7554/eLife.85263. Elife. 2023. PMID: 37548358 Free PMC article.

2

MYC - a thorn in the side of cancer immunity.

Spranger S, Gajewski TF, Kline J. Spranger S, et al. Cell Res. 2016 Jun;26(6):639-40. doi: 10.1038/cr.2016.50. Epub 2016 Apr 26. Cell Res. 2016. PMID: 27113275 Free PMC article.

3

Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.

Spranger S, Luke JJ, Bao R, Zha Y, Hernandez KM, Li Y, Gajewski AP, Andrade J, Gajewski TF. Spranger S, et al. Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7759-E7768. doi: 10.1073/pnas.1609376113. Epub 2016 Nov 11. Proc Natl Acad Sci U S A. 2016. PMID: 27837020 Free PMC article.

4

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.

Spranger S, Bao R, Gajewski TF. Spranger S, et al. Nature. 2015 Jul 9;523(7559):231-5. doi: 10.1038/nature14404. Epub 2015 May 11. Nature. 2015. PMID: 25970248

5

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.

Leisegang M, Wilde S, Spranger S, Milosevic S, Frankenberger B, Uckert W, Schendel DJ. Leisegang M, et al. Among authors: spranger s. J Clin Invest. 2010 Nov;120(11):3869-77. doi: 10.1172/JCI43437. Epub 2010 Oct 11. J Clin Invest. 2010. PMID: 20978348 Free PMC article.

6

WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.

Luke JJ, Bao R, Sweis RF, Spranger S, Gajewski TF. Luke JJ, et al. Among authors: spranger s. Clin Cancer Res. 2019 May 15;25(10):3074-3083. doi: 10.1158/1078-0432.CCR-18-1942. Epub 2019 Jan 11. Clin Cancer Res. 2019. PMID: 30635339 Free PMC article.

7

Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.

Gajewski TF, Corrales L, Williams J, Horton B, Sivan A, Spranger S. Gajewski TF, et al. Among authors: spranger s. Adv Exp Med Biol. 2017;1036:19-31. doi: 10.1007/978-3-319-67577-0_2. Adv Exp Med Biol. 2017. PMID: 29275462 Free PMC article. Review.

8

Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.

Spranger S, Javorovic M, Bürdek M, Wilde S, Mosetter B, Tippmer S, Bigalke I, Geiger C, Schendel DJ, Frankenberger B. Spranger S, et al. J Immunol. 2010 Jul 1;185(1):738-47. doi: 10.4049/jimmunol.1000060. Epub 2010 May 28. J Immunol. 2010. PMID: 20511554

9

Lymphatic vessels regulate immune microenvironments in human and murine melanoma.

Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, Gajewski TF, Alitalo K, Eikesdal HP, Wiig H, Swartz MA. Lund AW, et al. Among authors: spranger s. J Clin Invest. 2016 Sep 1;126(9):3389-402. doi: 10.1172/JCI79434. Epub 2016 Aug 15. J Clin Invest. 2016. PMID: 27525437 Free PMC article.

10

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

Evaristo C, Spranger S, Barnes SE, Miller ML, Molinero LL, Locke FL, Gajewski TF, Alegre ML. Evaristo C, et al. Among authors: spranger s. J Immunol. 2016 Apr 1;196(7):2933-8. doi: 10.4049/jimmunol.1501144. Epub 2016 Feb 22. J Immunol. 2016. PMID: 26903482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters